Perrigo Company plc (PRGO) Earnings Call Analysis

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic

15/25

Growth 2 Margin 1 Expansion 5 Platform 3 Financial 4

latest quarter score

Earnings Reports

15
Perigo (PRGO) Q2 2026: $600M Divestiture Proceeds Accelerate Deleveraging, Strategic Reviews Remain in Focus
August 05, 2026
17
Perigo (PRGO) Q1 2026: Store Brand OTC Share Surges 270bps, Offsetting Market Headwinds
May 06, 2026
16
Perigo (PRGO) Q4 2025: $320M Cost Takeout Anchors Resilience Amid -3.5% to +0.5% Core Sales Guide
February 26, 2026
14
Perigo (PRGO) Q3 2025: OTC Share Climbs 90bps as Strategic Reviews Reshape Portfolio
November 05, 2025
18
Perigo (PRGO) Q2 2025: Store Brand OTC Drives 15% Second-Half U.S. Growth Pivot
August 06, 2025
22
Perigo (PRGO) Q1 2025: Gross Margin Expands 440bps as Tariff Mitigation and Brand Growth Offset Macro Drag
July 07, 2025

Browse all companies